jc
@JadChahoud
Followers
831
Following
9K
Media
4
Statuses
3K
Genitourinary Medical Oncologist @MoffittNews @MoffittResearch
Joined April 2012
Single-Arm Pivotal Studies in Bacillus Calmette-Guérin–Unresponsive Non–Muscle-Invasive Bladder Cancer | @JCO_ASCO @ASCO @siadaneshmand @JNJNews
ascopubs.org
1
4
18
(1/6) Introducing an AR RIPTAC therapy, HLD-0915, for men with mCRPC by @HaldaTx We presented data from the FIH, phase 1 trial at the @AACR #Targets25 meeting. Here’s the Tweetorial for this active, tolerable, oral med and link to the slides https://t.co/mKbro4l0Or
1
16
47
(5/6) Most exciting part is this novel MOA has very encouraging prelim activity against mCRPC. In pts with ≥ 6 wks tx, PSA50 was 59%, PSA90 was 32%, PR in 5/5 pts with RECIST-evaluable, and activity regardless prior tx or genomic alterations
2
7
15
Together with my mentor @lab_rezvani Katy Rezvani @MDAndersonNews, I am excited to share our new review in Cancer Cell: “Engineered natural killer cells for cancer therapy”. Deeply grateful for Katy’s mentorship and her visionary leadership. #CARNK #Immunotherapy #SolidTumors
4
29
95
Congratulations to the legend, Dr. Maha Hussain, on receiving the @PCFnews Lifetime Achievement Award at #PCFRetreat25 👏 From groundbreaking drug approvals in #prostatecancer to an extraordinary legacy of mentorship—so fortunate to call you my mentor.@UroToday @PCF_Science
1
20
81
Impact of Systemic Therapy for Renal Cell Carcinoma With a Tumor Thrombus: Results From the Intercontinental Collaboration on Renal Cell Carcinoma Database - Clinical Genitourinary Cancer
clinical-genitourinary-cancer.com
MicroabstractThe role of systemic therapy in the management of these renal cell carcinoma with a tumor thrombus (RCCC-TT) patients is poorly understood. In this multi-institutional analysis, we study...
0
5
18
Join us today, Monday, October20th, 8.30-10 am, #ESMO25 Berlin👉for the “special symposium” on personalization of treatment in metastatic #ProstateCancer based on biomarkers👉Talk titles & Location info/map👇@OncoAlert @urotoday @PCF_Science
0
16
36
Honored to be part of GU scientific committee #ESMO2025 and co-chair the educational session on bladder cancer with @ReginaBarCar and present the current landscape on adjuvant setting Outstanding @PGrivasMDPhD @giannatempopatr @MichvdHeijden
@IBCG_BladderCA @myESMO
2
6
22
Nothing is impossible when super ⭐️ @OncHahn 👑 is leading this amazing team of thoughtful and bright friends and scientists @PavlosMsaouel onwards and upwards as 👑 Nizar would say 🥂
Congratulations to @OncHahn, @JadChahoud and the entire team on completing this randomized investigator-initiated multicenter trial. Many thought it was impossible for such a comparison to be completed but you turned it into reality. @neerajaiims @PGrivasMDPhD @montypal
0
3
13
Excited to see LenCabo published concomitant in @Annals_Oncology Plan to post a full tweetorial summarizing our results later @PavlosMsaouel
📢 #ESMO25 concomitant paper: results from the LenCabo phase II trial of lenvatinib + everolimus vs cabozantinib post PD-1 ICI in #mccRCC @OncHahn
https://t.co/4EmwlwVhqE
1
20
57
First glimpses into saruparib in PETRANHA by @AzadOncology Surprised by the comparable rates of anemia. Has encouraging initial activity but hard to differentiate from ARPI alone given study design. Await P3 data
2
9
19
IPD meta-analysis of XRT to the prostate in men with mHSPC, by @petegodolphin & STOPCAP team, at #ESMO25 Overall trends are for benefit in low volume and < 5 bone Mets. Many caveats persist as discussed by @DrYukselUrun
1
6
14
Check out my close friend and collaborator, @PavlosMsaouel, and I discuss RCC on the Cancerwise podcast for @MDAndersonNews
What new in renal cell carcinoma treatment? Drs. Andrew Hahn and Pavlos Msaouel discuss exciting new options for this type of kidney cancer in the latest Cancerwise podcast episode. Listen here: https://t.co/QSOi6SjzLF
#EndCancer
0
5
18
Thanks for the shoutout @DrChoueiri! Can’t wait to share the results of LenCabo with the community and hope it helps patients and clinicians.
One day to go for #ESMO25 — packed with practice changing talks! GU program is loaded… @myESMO @OncLive @OncoAlert
0
1
7
Many congratulations Luis and team. Truly a rising star ⭐️⭐️⭐️
Overview of the evolving landscape of systemic therapies for penile cancer — a rare field where high-quality evidence remains limited but is rapidly advancing. Congrats to @SalvadorjcMD for leading this effort and special thanks to @SpiessPhilippe & @JadChahoud for their
0
3
16
Overview of the evolving landscape of systemic therapies for penile cancer — a rare field where high-quality evidence remains limited but is rapidly advancing. Congrats to @SalvadorjcMD for leading this effort and special thanks to @SpiessPhilippe & @JadChahoud for their
1
6
43
MT @Lymphoma_Doc [2019 Nov 14] Remember to donate to CCF -> Great to see my friend @mtmdphd at the @ASCO board of directors meeting. Thank you to @ConquerCancerFd for funding our innovative research with a YIA and CDA, an incredible boost for early career oncologists. #lymsm
0
1
7
🧁What a treat to have @montypal on The Simply Oncology podcast discussing the Gut Microbiome & his work with CBM588 in #renalcancer Synergising the gut microbiome with immunotherapy is such an exciting space 🚀 Out soon💫 @RenalCancerNews @OncoAlert
1
6
33
✍️Mark your calendar for our upcoming space❗️ Fellowship Rank Order List: Insights and Practical Tips‼️ 🌟Speaker: @Taha_CancerDoc, Fellowship APD at University of Oklahoma 🌟Host: @DrSAHaddad, Fellow at UT Health San Antonio 🗓️Wednesday, October 15, 2025 📍X space, 6 pm EST
1
13
35
0
3
35